Literature DB >> 9603330

No evidence for a role of modified live virus vaccines in the emergence of canine parvovirus.

U Truyen1, K Geissler, C R Parrish, W Hermanns, G Siegl.   

Abstract

In this study the early evolution and potential origins of canine parvovirus (CPV) were examined. We cloned and sequenced the VP2 capsid protein genes of three German CPV strains isolated in 1979-1980, as well as two feline panleukopenia virus (FPV) vaccine viruses that were previously shown to have some restriction enzyme cleavage sites in common with CPV. Other partial VP2 gene sequences were obtained by amplifying CPV DNA from paraffin-embedded tissues of dogs which were early parvovirus disease cases in Germany in 1978-1979. Sequences were analysed with respect to their evolutionary relationships to other CPV and FPV isolates. Those analyses did not support the hypothesis that CPV emerged as a variant of an FPV vaccine virus. Neither did they reveal ancestral sequences among the very early CPV isolates examined. Other possible sources for the origin of CPV are examined, including the involvement of viruses from wild carnivores.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9603330     DOI: 10.1099/0022-1317-79-5-1153

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  5 in total

1.  Carnivore Parvovirus Ecology in the Serengeti Ecosystem: Vaccine Strains Circulating and New Host Species Identified.

Authors:  Olga Calatayud; Fernando Esperón; Sarah Cleaveland; Roman Biek; Julius Keyyu; Ernest Eblate; Elena Neves; Tiziana Lembo; Felix Lankester
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

2.  Feline host range of canine parvovirus: recent emergence of new antigenic types in cats.

Authors:  Yasuhiro Ikeda; Kazuya Nakamura; Takayuki Miyazawa; Eiji Takahashi; Masami Mochizuki
Journal:  Emerg Infect Dis       Date:  2002-04       Impact factor: 6.883

3.  Molecular characterization of canine parvovirus-2 variants circulating in Tunisia.

Authors:  Leila Touihri; Imen Bouzid; Rahma Daoud; Costantina Desario; Amel Founa El Goulli; Nicola Decaro; Abderrazak Ghorbel; Canio Buonavoglia; Chokri Bahloul
Journal:  Virus Genes       Date:  2008-12-28       Impact factor: 2.332

Review 4.  [How to define the species barrier to pathogen transmission?].

Authors:  Philippe Sansonetti
Journal:  Bull Acad Natl Med       Date:  2006-03       Impact factor: 0.144

Review 5.  Cross-species transfer of viruses: implications for the use of viral vectors in biomedical research, gene therapy and as live-virus vaccines.

Authors:  Derrick Louz; Hans E Bergmans; Birgit P Loos; Rob C Hoeben
Journal:  J Gene Med       Date:  2005-10       Impact factor: 4.565

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.